Comparative Study of Antithrombotic Effect of a Low Molecular Weight Heparin and Unfractionated Heparin in an ex Vivo Model of Deep Arterial Injury

By Roque M.   Rauch U.   Reis E.D.   Chesebro J.H.   Fuster V.   Badimon J.J.  

Thrombosis Research, Vol. 98, Iss. 6, 2000-06 ,pp. : 499-505

Elsevier

Access to resources Recommend Favorite

An Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor Potentiates Tissue-Type Plasminogen Activator-Induced Thrombolysis in a Rabbit Jugular Vein Thrombolysis Model *

By Nagashima M.   Werner M.   Wang M.   Zhao L.   Light D.R.   Pagila R.   Morser J.   Verhallen P.  

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite

Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy

By Callas D.D.   Fareed J.  

Thrombosis Research, Vol. 78, Iss. 5, 1995-06 ,pp. : 457-460

Elsevier

Access to resources Recommend Favorite

Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover

By Roschitz B.   Beitzke A.   Gamillscheg A.   Sudi K.   Koestenberger M.   Leschnik B.   Muntean W.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

Antithrombotic Effects and Bleeding Time of Thrombin Inhibitors and Warfarin in the Rat - Ground for improvement

By Elg M.   Gustafsson D.   Carlsson S.  

Thrombosis Research, Vol. 94, Iss. 3, 1999-05 ,pp. : 187-197

Elsevier

Access to resources Recommend Favorite